COMP <GO>
RDNT vs CDNA // RETURN ON INVESTED CAPITAL (ROIC)
RadNet Inc. (NASDAQ) VS. CareDx Inc. (NASDAQ) • 15-METRIC TALLY: RDNT 5
— CDNA 4
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: RDNT
LAST: $73.10 (-0.53%) • MKT CAP: $5.78B
roic
3.50%
LAST: $85.88 (-1.75%) • MKT CAP: $4.59B
roic
-8.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RDNT VS. CDNA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RDNT | CDNA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 3.50% | -8.20% | +11.70 | RDNT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 98.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.16% | 0.67% | +4.49 | RDNT | /fcf-yield <GO> |
| Operating Margin | 3.00% | -8.10% | +11.10 | RDNT | /operating-margins <GO> |
| Net Profit Margin | -0.90% | -5.60% | +4.70 | RDNT | /net-margins <GO> |
| Revenue Growth (YoY) | 11.50% | 13.80% | -2.30 | CDNA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.15 | 19.22 | -17.07 | CDNA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | CDNA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.9 | 67.4 | -9.50 | CDNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.06 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.78B | $4.59B | $1.19B | RDNT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RDNT REV | CDNA REV | RDNT GROSS % | CDNA GROSS % | RDNT FCF | CDNA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.04B | $379.8M | — | — | $298.8M | $24.9M |
| FY 2024 | $1.83B | $333.8M | — | — | $233.0M | $23.0M |
| FY 2023 | $1.62B | $280.3M | — | — | $220.9M | -$31.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RDNT // BETA —
CDNA // BETA 1.06